Apollomics

About:

Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.

Website: https://www.apollomicsinc.com

Twitter/X: apollomics

Top Investors: OrbiMed, K2VC, CMB International Capital Corporation, WR Hambrecht, Pan-Lin Capital

Description:

Apollomics is an innovative biopharmaceutical company committed to the discovery and development of mono- and combination-oncology therapies to harness the immune system and target specific molecular pathways to eradicate cancer. The company’s existing pipeline consists of several development-stage assets, including the novel, humanized monoclonal antibodies that restore the body’s immune system to recognize and kill cancer cells, and targeted therapies against uncontrolled growth signaling pathways.